|
US6872710B2
(en)
*
|
1997-07-25 |
2005-03-29 |
Inspire Pharmaceuticals, Inc. |
Di(uridine 5′)-tetraphosphate and salts thereof
|
|
ES2302881T3
(es)
|
1997-07-29 |
2008-08-01 |
Alcon Laboratories, Inc. |
Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
|
|
ATE225392T1
(de)
|
1997-07-29 |
2002-10-15 |
Alcon Lab Inc |
Konditionierungslösungen für die pflege von harten kontaktlinsen
|
|
US7084130B2
(en)
*
|
2001-12-11 |
2006-08-01 |
Alcon, Inc. |
Intraocular irrigating solution having improved flow characteristics
|
|
WO2002049611A2
(en)
|
2000-12-20 |
2002-06-27 |
Alcon, Inc. |
Ophthalmic lubricating solution adapted for use in lasik surgery
|
|
AU2002230504A1
(en)
|
2000-12-20 |
2002-07-01 |
Alcon Universal Ltd. |
Ophthalmic irrigating solution adapted for use in lasik surgery
|
|
CA2431368C
(en)
*
|
2000-12-20 |
2006-08-08 |
Alcon, Inc. |
Intraocular irrigating solution having improved flow characteristics
|
|
US20090258955A1
(en)
*
|
2000-12-20 |
2009-10-15 |
Alcon, Inc. |
Intraocular irrigating solution having improved flow characteristics
|
|
AU2002228955B2
(en)
*
|
2000-12-20 |
2005-09-29 |
Alcon Inc. |
Solution for removing cataracts via liquefracture
|
|
WO2003001030A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Bj Services Company |
Fracturing fluids and methods of making and using same
|
|
FR2832223B1
(fr)
|
2001-11-15 |
2005-01-14 |
Cit Alcatel |
Composant monolithique electro-optique multisections
|
|
KR20040073503A
(ko)
*
|
2001-12-21 |
2004-08-19 |
알콘, 인코퍼레이티드 |
안과용 및 이과용 약제학적 조성물의 점도 및 기타물리학적 성질을 개질시키기 위한 무기 나노입자의 용도
|
|
EP1455804A4
(en)
*
|
2001-12-21 |
2005-01-05 |
Alcon Inc |
USE OF NANOTEILES AS CARRIERS OF BIOCIDES IN OPHTHALMIC COMPOSITIONS
|
|
JP2005514429A
(ja)
*
|
2001-12-21 |
2005-05-19 |
アルコン、インコーポレイテッド |
眼／耳用薬物のキャリヤーとしての合成無機質ナノ粒子の使用
|
|
MXPA04008171A
(es)
*
|
2002-02-22 |
2004-11-26 |
Pharmacia Corp |
Formulacion oftalmica con sistema de goma.
|
|
JP4653861B2
(ja)
|
2002-06-25 |
2011-03-16 |
ローディア インク． |
電子ビームによる多糖類の分子量低減
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
BRPI0312075B8
(pt)
*
|
2002-06-25 |
2016-09-13 |
Rhodia |
método para enxerto de um monômero insaturado em um polissacarídeo.
|
|
KR101016595B1
(ko)
|
2002-07-31 |
2011-02-22 |
센주 세이야꾸 가부시키가이샤 |
수성액제 및 광안정화된 수성액제
|
|
US8877168B1
(en)
|
2002-07-31 |
2014-11-04 |
Senju Pharmaceuticals Co., Ltd. |
Aqueous liquid preparations and light-stabilized aqueous liquid preparations
|
|
WO2004054542A2
(en)
|
2002-12-13 |
2004-07-01 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
|
AU2012205283B2
(en)
*
|
2003-06-13 |
2014-08-07 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of two polymers
|
|
TWI336257B
(en)
|
2003-06-13 |
2011-01-21 |
Alcon Inc |
Ophthalmic compositions containing a synergistic combination of three polymers
|
|
KR101131056B1
(ko)
*
|
2003-06-13 |
2012-04-23 |
알콘, 인코퍼레이티드 |
시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
|
|
US7947295B2
(en)
|
2003-06-13 |
2011-05-24 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of two polymers
|
|
US7914803B2
(en)
|
2003-06-13 |
2011-03-29 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of three polymers
|
|
WO2005060933A1
(en)
*
|
2003-12-11 |
2005-07-07 |
Alcon, Inc. |
Ophthalmic compositions containing a polysaccharide/borate gelling system
|
|
US20050129770A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Alcon, Inc. |
Ophthalmic compositions containing a PVA/borate gelling system
|
|
US20050137166A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Alcon, Inc. |
Use of cooling agents to relieve mild ocular irritation and enhance comfort
|
|
JP2007524690A
(ja)
*
|
2004-02-17 |
2007-08-30 |
ヴェーリ・インター・アーゲー |
活性物質の生体内利用効率を高めるためのガラクトマンナン及び／又はグルコマンナン
|
|
DE602005016659D1
(de)
*
|
2004-03-18 |
2009-10-29 |
R Tech Ueno Ltd |
Wässrige zusammensetzung mit einem thiazol-derivat
|
|
US7022740B2
(en)
*
|
2004-04-29 |
2006-04-04 |
Leonard Mackles |
Lubricious ophthalmic solutions
|
|
KR100665299B1
(ko)
*
|
2004-06-10 |
2007-01-04 |
서울반도체 주식회사 |
발광물질
|
|
WO2006017589A2
(en)
*
|
2004-08-03 |
2006-02-16 |
Rhodia Inc., |
Polysaccharide graft copolymers and their use in personal car eapplications
|
|
JP4771044B2
(ja)
*
|
2004-09-15 |
2011-09-14 |
大正製薬株式会社 |
粘膜適用液剤
|
|
EP3103477A1
(en)
|
2004-09-17 |
2016-12-14 |
Durect Corporation |
Sustained local anesthetic composition containing saib
|
|
US20070059274A1
(en)
*
|
2004-12-01 |
2007-03-15 |
Bahram Asgharian |
Ophthalmic compositions containing a PVA/borate gelling system
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
WO2007025142A2
(en)
*
|
2005-08-26 |
2007-03-01 |
Ladd Byron S |
Gel compositions comprising a combination of an antiseptic and an anesthetic agent for treating surface areas in medical and surgical procedures
|
|
US20100130580A1
(en)
*
|
2006-01-25 |
2010-05-27 |
Aciex Therapeutics, Inc. |
Formulations and Methods for Treating Dry Eye
|
|
CA2636646A1
(en)
*
|
2006-01-25 |
2007-08-02 |
Aciex, Inc. |
Formulations and methods for treating dry eye
|
|
WO2007130364A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Riolan Technologies, Inc. |
Compositions, methods, and kits for treating dry eye
|
|
TWI394564B
(zh)
*
|
2006-09-21 |
2013-05-01 |
Alcon Res Ltd |
自行保存型水性藥學組成物
|
|
WO2008036855A2
(en)
*
|
2006-09-21 |
2008-03-27 |
Alcon Research, Ltd. |
Self-preserved aqueous pharmaceutical compositions
|
|
BRPI0717093A2
(pt)
*
|
2006-09-28 |
2013-11-26 |
Alcon Res Ltd |
Composições farmacêuticas aquosas autopreservadas
|
|
US8337883B2
(en)
|
2006-11-03 |
2012-12-25 |
Durect Corporation |
Transdermal delivery systems
|
|
AU2007343701B2
(en)
*
|
2007-01-16 |
2013-01-31 |
Texas Tech University System |
Method and apparatus for gender selection based on pH
|
|
US20080193407A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Alcon, Inc. |
Ophthalmic compositions containing a synergistic combination of three polymers
|
|
JP2010520766A
(ja)
*
|
2007-03-09 |
2010-06-17 |
コーニング インコーポレイテッド |
細胞培養用三次元ガムマトリックス、製造方法および使用方法
|
|
JP2010520765A
(ja)
*
|
2007-03-09 |
2010-06-17 |
コーニング インコーポレイテッド |
細胞培養用ガムコーティング、製造方法および使用方法
|
|
AU2008262491A1
(en)
*
|
2007-05-24 |
2008-12-18 |
Aciex Therapeutics, Inc. |
Formulations and methods for treating dry eye
|
|
US20090131303A1
(en)
*
|
2007-11-16 |
2009-05-21 |
Bor-Shyue Hong |
Methods and compositions for treating dry eye
|
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
US7795316B1
(en)
|
2007-12-19 |
2010-09-14 |
Alcon Research, Ltd. |
Topical ophthalmic compositions containing tobramycin and dexamethasone
|
|
PT2254549E
(pt)
*
|
2008-03-17 |
2014-01-30 |
Alcon Res Ltd |
Composições farmacêuticas aquosas que contêm complexos de borato-poliol
|
|
TWI526213B
(zh)
*
|
2008-04-26 |
2016-03-21 |
愛爾康研究有限公司 |
聚合性人工淚液系統
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
CA2749809C
(en)
*
|
2009-02-05 |
2017-03-14 |
Alcon Research, Ltd. |
Process for purifying guar
|
|
TW201039815A
(en)
|
2009-04-13 |
2010-11-16 |
Resolvyx Pharmaceuticals Inc |
Compositions and methods for the treatment of inflammation
|
|
TWI489997B
(zh)
|
2009-06-19 |
2015-07-01 |
Alcon Res Ltd |
含有硼酸－多元醇錯合物之水性藥學組成物
|
|
TWI547522B
(zh)
*
|
2009-07-07 |
2016-09-01 |
愛爾康研究有限公司 |
環氧乙烷環氧丁烷嵌段共聚物組成物
|
|
WO2011068872A2
(en)
*
|
2009-12-03 |
2011-06-09 |
Alcon Research, Ltd. |
Carboxyvinyl polymer-containing nanoparticle suspension
|
|
TWI478730B
(zh)
*
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
|
MX2012012826A
(es)
|
2010-05-05 |
2013-01-28 |
Alcon Res Ltd |
Formulaciones de galactomanana oftalmicas estabilizadas.
|
|
CA2801731A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Alcon Research, Ltd. |
Topical ophthalmic suspensions containing tobramycin and dexamethasone
|
|
CN103249737B
(zh)
|
2010-10-26 |
2016-06-08 |
马尔斯公司 |
作为精氨酸酶抑制剂的硼酸盐
|
|
CN104039307A
(zh)
|
2011-04-22 |
2014-09-10 |
爱尔康研究有限公司 |
具有包含两种不同粘度增强剂的粘度增强体系的眼用组合物
|
|
MX2013012308A
(es)
|
2011-04-22 |
2014-01-31 |
Alcon Res Ltd |
Composicion oftalmica con un sistema de mejoramiento de viscosidad de dos agentes mejoradores de viscosidad diferentes.
|
|
EA201692166A1
(ru)
|
2011-11-21 |
2017-07-31 |
Калитера Байосайенсиз Инк. |
Гетероциклические ингибиторы глютаминазы
|
|
TW201336527A
(zh)
*
|
2012-02-10 |
2013-09-16 |
Alcon Res Ltd |
具增強的穩定性之水性藥學組成物
|
|
UA113434C2
(uk)
|
2012-05-04 |
2017-01-25 |
Алкон Рісерч, Лтд. |
Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням
|
|
CN102860949B
(zh)
*
|
2012-08-31 |
2014-07-02 |
马应龙药业集团股份有限公司 |
眼部抗皱护肤品及其制备方法
|
|
BR112015010955A2
(pt)
|
2012-11-16 |
2017-07-11 |
Calithera Biosciences Inc |
inibidores de glutaminase heterocíclica
|
|
EP2983468A4
(en)
|
2013-03-15 |
2016-09-07 |
Durect Corp |
COMPOSITIONS WITH RHEOLOGY MODIFIER TO REDUCE RESOLUTION VARIABILITY
|
|
US9630909B2
(en)
|
2013-06-27 |
2017-04-25 |
Mylan Laboratories Ltd |
Process for the preparation of nepafenac
|
|
WO2015055301A1
(en)
|
2013-10-15 |
2015-04-23 |
Pharmathen S.A. |
Preservative free pharmaceutical compositions for ophthalmic administration
|
|
FR3000391B3
(fr)
|
2013-11-12 |
2015-02-20 |
Pharmathen Sa |
Compositions pharmaceutiques sans conservateur pour administration ophtalmique
|
|
CN103572651B
(zh)
*
|
2013-11-25 |
2016-05-04 |
齐鲁工业大学 |
一种改性塔拉胶及其制备方法与应用
|
|
WO2015142853A1
(en)
*
|
2014-03-17 |
2015-09-24 |
Encompass Development, Inc. |
Ocular formulations
|
|
CN107027291B
(zh)
|
2014-06-13 |
2020-10-30 |
卡利泰拉生物科技公司 |
用谷氨酰胺酶抑制剂的组合疗法
|
|
JP6889101B2
(ja)
|
2014-08-07 |
2021-06-18 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
グルタミナーゼ阻害剤の結晶形態
|
|
JP6663909B2
(ja)
|
2014-08-13 |
2020-03-13 |
エオラス セラピューティクス， インコーポレイテッド |
オレキシンレセプターモジュレーターとしてのジフルオロピロリジン
|
|
WO2016061145A1
(en)
|
2014-10-13 |
2016-04-21 |
Symic Biomedical, Inc. |
Synthetic proteoglycans for preventing tissue adhesion
|
|
WO2016061147A1
(en)
|
2014-10-13 |
2016-04-21 |
John Eric Paderi |
Luminal vessel coating for arteriovenous fistula
|
|
WO2016065083A1
(en)
|
2014-10-21 |
2016-04-28 |
Symic Biomedical, Inc. |
Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
|
|
SG11201706908PA
(en)
|
2015-03-10 |
2017-09-28 |
Aurigene Discovery Tech Ltd |
1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
|
MA42269A
(fr)
|
2015-06-23 |
2018-05-02 |
Calithera Biosciences Inc |
Compositions et procédés d'inhibition de l'activité de l'arginase
|
|
WO2017023935A1
(en)
|
2015-08-03 |
2017-02-09 |
Ecolab Usa Inc. |
Compositions and methods for delayed crosslinking in hydraulic fracturing fluids
|
|
GB2542881B
(en)
|
2015-10-02 |
2020-01-01 |
Carr Andrew |
Crystal forms of ß-nicotinamide mononucleotide
|
|
JP6971239B2
(ja)
|
2015-10-05 |
2021-11-24 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
グルタミナーゼ阻害剤とイムノオンコロジー薬剤との併用療法
|
|
US20170112941A1
(en)
|
2015-10-13 |
2017-04-27 |
Symic Ip, Llc |
Ve-cadherin binding bioconjugate
|
|
AU2016344349B2
(en)
|
2015-10-25 |
2022-05-19 |
Iview Therapeutics, Inc. |
Pharmaceutical formulations that form gel in situ
|
|
PT3368541T
(pt)
|
2015-10-30 |
2020-07-06 |
Calithera Biosciences Inc |
Composições e métodos para inibição da atividade da arginase
|
|
JP7019585B2
(ja)
|
2015-11-16 |
2022-02-15 |
アヴァロ セラピューティクス，インコーポレーテッド |
核酸プロドラッグ
|
|
JP6703408B2
(ja)
*
|
2016-01-30 |
2020-06-03 |
国立大学法人 筑波大学 |
ポリイオンコンプレックスを有効成分とするドライアイ処置用組成物
|
|
HUE059280T2
(hu)
|
2016-02-12 |
2022-11-28 |
Astrazeneca Ab |
Halogén-szubsztituált piperidinek mint orexin receptor modulátorok
|
|
US10087363B2
(en)
*
|
2016-03-15 |
2018-10-02 |
Baker Hughes, A Ge Company, Llc |
Using borated galactomannan to enhance swelling of superabsorbents for fracturing applications
|
|
AU2017252122B2
(en)
|
2016-04-22 |
2023-02-09 |
Viking Therapeutics, Inc. |
Use of Thyroid beta-Agonists
|
|
US10793590B2
(en)
|
2016-06-03 |
2020-10-06 |
President And Fellows Of Harvard College |
Antifungal compounds
|
|
AU2017292791B2
(en)
|
2016-07-06 |
2023-05-25 |
Orient Pharma Co., Ltd. |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
US10550315B2
(en)
|
2016-07-15 |
2020-02-04 |
Ecolab Usa Inc. |
Compositions and methods for delayed crosslinking in hydraulic fracturing fluids
|
|
EP3503904A4
(en)
|
2016-08-25 |
2020-03-25 |
California Institute of Technology |
ASCAROSIDE TREATMENT OF EOSINOPHILIC OESOPHAGITIS
|
|
WO2018049008A1
(en)
|
2016-09-07 |
2018-03-15 |
Trustees Of Tufts College |
Dash inhibitors, and uses related thereto
|
|
CN110234656B
(zh)
|
2016-09-09 |
2023-02-28 |
卡利泰拉生物科技公司 |
外核苷酸酶抑制剂及其使用方法
|
|
EP3509583B1
(en)
|
2016-09-09 |
2021-06-30 |
The Regents of the University of California |
Estrogen receptor ligands, compositions and methods related thereto
|
|
BR112019004992A2
(pt)
|
2016-09-14 |
2019-06-04 |
Univ Vanderbilt |
inibição da sinalização de bmp, compostos, composições e usos destes
|
|
JP7203018B2
(ja)
|
2016-09-26 |
2023-01-12 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
クロモボックスタンパク質阻害剤およびその使用
|
|
CN110352063A
(zh)
|
2016-11-08 |
2019-10-18 |
卡里塞拉生物科学股份公司 |
精氨酸酶抑制剂组合疗法
|
|
ES2881395T3
(es)
|
2016-12-22 |
2021-11-29 |
Calithera Biosciences Inc |
Composiciones y métodos para inhibir la actividad de la arginasa
|
|
CN110430880A
(zh)
|
2017-01-18 |
2019-11-08 |
范德比尔特大学 |
作为选择性bmp抑制剂的稠合杂环化合物
|
|
EA201991916A1
(ru)
|
2017-02-24 |
2020-01-21 |
Мерк Патент Гмбх |
1,4,6-ТРИЗАМЕЩЕННЫЕ-2-АЛКИЛ-1H-БЕНЗО[d]ИМИДАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ДИГИДРООРОТАТНЫХ ОКСИГЕНАЗНЫХ ИНГИБИТОРОВ
|
|
SI3600270T1
(sl)
|
2017-03-31 |
2023-10-30 |
Aurigene Oncology Limited |
Spojine in sestavki za zdravljenje hematoloških motenj
|
|
WO2018209288A1
(en)
|
2017-05-12 |
2018-11-15 |
Massachusetts Institute Of Technology |
Argonaute protein-double stranded rna complexes and uses related thereto
|
|
WO2018223032A1
(en)
|
2017-06-02 |
2018-12-06 |
Stealth Biotherapeutics Corp. |
Crystalline salt forms of sbt-20
|
|
US10526334B2
(en)
|
2017-07-19 |
2020-01-07 |
California Institute Of Technology |
Methods for preparing bis-tetrahydroisoquinoline-containing compounds
|
|
JP2020536853A
(ja)
|
2017-10-04 |
2020-12-17 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
転写因子ｓａｌｌ４の小分子阻害およびその使用
|
|
KR20240151258A
(ko)
|
2017-10-11 |
2024-10-17 |
오리진 온콜로지 리미티드 |
3-치환된 1,2,4-옥사다이아졸의 결정질 형태
|
|
EP3697386B1
(en)
|
2017-10-19 |
2023-07-26 |
Signpath Pharma, Inc. |
Liquid compositions for peroral use comprising phosphatidylglycerol derivatives and thixotropic excipients for treating cardiac channelopathies caused by pharmacological agents
|
|
EA202090497A1
(ru)
|
2017-10-31 |
2020-11-23 |
Кьюрис, Инк. |
Соединения и композиции для лечения гематологических нарушений
|
|
MX2020004531A
(es)
|
2017-11-03 |
2020-08-03 |
Aurigene Discovery Tech Ltd |
Inhibidores dobles de tim-3 y las vias de pd-1.
|
|
KR20200084333A
(ko)
|
2017-11-06 |
2020-07-10 |
오리진 디스커버리 테크놀로지스 리미티드 |
면역조절을 위한 병행 요법
|
|
BR112020012476A2
(pt)
|
2017-12-22 |
2020-11-24 |
Medimmune Limited |
moduladores de moléculas pequenas do domínio btb de keap1
|
|
MX2020008711A
(es)
|
2018-02-21 |
2022-09-23 |
Alcon Inc |
Emulsión oftálmica a base de lípidos.
|
|
US10745400B2
(en)
|
2018-03-14 |
2020-08-18 |
Vanderbuilt University |
Inhibition of BMP signaling, compounds, compositions and uses thereof
|
|
MX2021000895A
(es)
|
2018-07-27 |
2021-08-24 |
California Inst Of Techn |
Inhibidores de cinasas dependientes de ciclinas (cdk) y usos de los mismos.
|
|
CN110787126A
(zh)
*
|
2018-08-03 |
2020-02-14 |
武汉武药科技有限公司 |
一种盐酸莫西沙星眼用凝胶及其制备方法
|
|
CN113038945A
(zh)
|
2018-09-05 |
2021-06-25 |
通用医疗公司 |
细胞因子释放综合征的治疗方法
|
|
WO2020056109A1
(en)
|
2018-09-12 |
2020-03-19 |
The Board Of Regents Of The University Of Oklahoma |
Combination cancer therapies
|
|
AU2019364631B2
(en)
|
2018-10-26 |
2025-05-01 |
Keros Therapeutics, Inc. |
Crystal forms of an ALK2 inhibitor
|
|
US12274898B2
(en)
|
2018-10-31 |
2025-04-15 |
Intocell, Inc. |
Substituted benzodiazepines as antibody-drug conjugates
|
|
WO2020123449A1
(en)
|
2018-12-10 |
2020-06-18 |
The General Hospital Corporation |
Cromolyn esters and uses thereof
|
|
MX2021008533A
(es)
|
2019-01-18 |
2021-08-19 |
Astrazeneca Ab |
Inhibidores de la pcsk9 y metodos de uso de los mismos.
|
|
CA3131753A1
(en)
|
2019-03-14 |
2020-09-17 |
Astrazeneca Ab |
Lanabecestat for weight loss
|
|
CN113874375A
(zh)
|
2019-06-03 |
2021-12-31 |
株式会社大分大学先端医学研究所 |
用于治疗狂犬病的环状酰胺化合物及其方法
|
|
TWI757773B
(zh)
*
|
2019-06-28 |
2022-03-11 |
瑞士商愛爾康公司 |
眼用組成物
|
|
MX2022003324A
(es)
*
|
2019-09-18 |
2022-04-18 |
Alcon Inc |
Insertos oculares de hidrogel blando envasados en humedo.
|
|
KR20220100625A
(ko)
|
2019-11-12 |
2022-07-15 |
젠자임 코포레이션 |
결핍된 cftr 활성에 의해 매개되는 질환 및 병태를 치료하기 위한 6원 헤테로아릴아미노설폰아미드
|
|
WO2021113809A1
(en)
|
2019-12-05 |
2021-06-10 |
Genzyme Corporation |
Arylamides and methods of use thereof
|
|
WO2021113806A1
(en)
|
2019-12-05 |
2021-06-10 |
Genzyme Corporation |
Arylamides and methods of use thereof
|
|
WO2021125800A1
(ko)
|
2019-12-16 |
2021-06-24 |
울산과학기술원 |
신생혈관형성인자의 억제를 위한 화합물 및 그 용도
|
|
KR20220140711A
(ko)
|
2020-01-13 |
2022-10-18 |
듀렉트 코퍼레이션 |
불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
|
|
BR112022022535A2
(pt)
|
2020-05-05 |
2023-04-25 |
Nuvalent Inc |
Composto, composição farmacêutica, método de tratamento de câncer, método de inibição seletiva, método de redução de um nível de ros1 ou alk
|
|
PH12022552787A1
(en)
|
2020-05-05 |
2024-03-25 |
Nuvalent Inc |
Heteroaromatic macrocyclic ether chemotherapeutic agents
|
|
WO2022221227A1
(en)
|
2021-04-13 |
2022-10-20 |
Nuvalent, Inc. |
Amino-substituted heterocycles for treating cancers with egfr mutations
|
|
EP4396176A1
(en)
|
2021-09-03 |
2024-07-10 |
Genzyme Corporation |
Indole compounds and uses thereof in the treatement of cystic fibrosis
|
|
IL311038A
(en)
|
2021-09-03 |
2024-04-01 |
Genzyme Corp |
Indole compounds and methods of use
|
|
US12043626B2
(en)
|
2021-10-01 |
2024-07-23 |
Nuvalent, Inc. |
Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
|
|
CA3231608A1
(en)
|
2021-10-01 |
2023-04-06 |
Amit M. Deshpande |
Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds
|
|
CN114191378A
(zh)
*
|
2021-11-23 |
2022-03-18 |
温州医科大学附属眼视光医院 |
一种地夸磷索缓释凝胶及其制备方法与应用
|
|
WO2023187672A1
(en)
|
2022-03-31 |
2023-10-05 |
Alcon Inc. |
Ophthalmic compositions
|
|
EP4504189A1
(en)
|
2022-04-07 |
2025-02-12 |
Nuvalent, Inc. |
Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,10,11,23-pentaazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(24),2(6),4,8,11,13,15,17,21(25),22-decaen-22-amine
|
|
CN119072481A
(zh)
|
2022-04-07 |
2024-12-03 |
纽威伦特公司 |
杂芳族巨环醚化合物的固体形式、药物组合物和制备
|
|
WO2023224961A1
(en)
|
2022-05-16 |
2023-11-23 |
Exelixis, Inc. |
Cancer therapy using a combination of a cdk7 inhibitor with an oral serd
|
|
AU2023317392A1
(en)
|
2022-08-04 |
2025-02-20 |
Dks Co. Ltd. |
Cyclic peptide derivative, method for producing same, and composition
|
|
EP4568969A1
(en)
|
2022-08-12 |
2025-06-18 |
Nuvalent, Inc. |
Heteroaromatic macrocyclic ether compounds
|
|
WO2024036097A1
(en)
|
2022-08-12 |
2024-02-15 |
Nuvalent, Inc. |
Heteroaromatic macrocyclic ether compounds and isotopologues thereof
|
|
EP4578856A1
(en)
|
2022-09-30 |
2025-07-02 |
Ubience Inc. |
Heterocyclic compound
|
|
JPWO2024071370A1
(el)
|
2022-09-30 |
2024-04-04 |
|
|
|
AU2023364043A1
(en)
|
2022-10-19 |
2025-04-10 |
Nuvalent, Inc. |
Heteroaromatic macrocyclic ether chemotherapeutic agents
|
|
WO2024096066A1
(ja)
|
2022-11-04 |
2024-05-10 |
第一工業製薬株式会社 |
中枢神経系損傷疾患を処置または予防するための環状ペプチド誘導体組成物
|
|
JPWO2024096067A1
(el)
|
2022-11-04 |
2024-05-10 |
|
|
|
WO2024233456A1
(en)
|
2023-05-05 |
2024-11-14 |
The Board Of Regents Of The University Of Oklahoma |
Variants of adrenomedullin (am) and adrenomedullin 2/intermedin (am2/imd) and methods of use
|
|
WO2025042868A1
(en)
|
2023-08-23 |
2025-02-27 |
The Board Of Regents Of The University Of Oklahoma |
Combinations of heteroarotinoids and glycolytic inhibitors for use as cancer treatments
|
|
WO2025072117A1
(en)
|
2023-09-25 |
2025-04-03 |
Nuvalent, Inc. |
Heteroaromatic macrocyclic ether compounds and isotopologues thereof
|
|
WO2025072120A1
(en)
|
2023-09-25 |
2025-04-03 |
Nuvalent, Inc. |
Heteroaromatic macrocyclic ether compounds
|
|
WO2025085360A1
(en)
|
2023-10-16 |
2025-04-24 |
The Board Of Regents Of The University Of Oklahoma |
Heteroarotinoids and/or cdk4/6 inhibitors for treating human papillomavirus (hpv)-induced dysplasias, warts, and cancer in hpv-infected subjects
|